Peng-Ru Chen

发表

Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis

Wenjie Liu, Geng-wei Huo, Peng-Ru Chen, 2022, Frontiers in Immunology.

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma

Wen-jing Ruan, W. Yi, Xue Yu, 2022, Frontiers in Immunology.

A bibliometric and scientific knowledge-map study of the chimeric antigen receptor (CAR) natural killer (NK) cell-related research from 2010 to 2022

Lele Miao, Peng-Ru Chen, Juan Zhang, 2022, Frontiers in Immunology.

Dysregulated Hypothalamic–Pituitary–Adrenal Axis Is Associated With Increased Inflammation and Worse Outcomes After Ischemic Stroke in Diabetic Mice

Peng-Ru Chen, Sehee Kim, Eunhee Kim, 2022, Frontiers in Immunology.

A novel immune-related model to predict prognosis and responsiveness to checkpoint and angiogenesis blockade therapy in advanced renal cancer

Xiaoping Yu, Lian Jian, Peng-Ru Chen, 2023, Frontiers in Oncology.

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood

Wenjun Zou, Xuelian Chen, Libo Cheng, 2023, Frontiers in Immunology.

Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells

Arun Sharma, Lovika Mittal, Shailendra Asthana, 2023, Frontiers in Oncology.

White sweet potato ameliorates hyperglycemia and regenerates pancreatic islets in diabetic mice

L. Shyur, Chiao-Ming Chen, C. Shih, 2020, Food & nutrition research.